5. 進行性核上性麻痺 Progressive supranuclear palsy Clinical trials / Disease details


臨床試験数 : 95 薬物数 : 120 - (DrugBank : 40) / 標的遺伝子数 : 65 - 標的パスウェイ数 : 108

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04734379
(ClinicalTrials.gov)
January 22, 202118/1/2021Rho Kinase (ROCK) Inhibitor in Tauopathies - 1A Phase 2a Open-Label Preliminary Safety, Tolerability, and Biomarker Study of Oral Fasudil in Patients With the 4-Repeat Tauopathies of Progressive Supranuclear Palsy-Richardson Syndrome or Corticobasal Syndrome.Progressive Supranuclear Palsy;Corticobasal SyndromeDrug: FasudilWoolsey PharmaceuticalsNULLActive, not recruiting35 Years80 YearsAll15Phase 2United States